{"organizations": [], "uuid": "b6dccfee93c5b2e42dc152b3e5d20778ae303606", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-proteostasis-therapeutics-co-astel/brief-proteostasis-therapeutics-co-astellas-pharma-entered-into-amendment-no-6-to-collaboration-license-agreement-idUSFWN1S00J9", "country": "US", "domain_rank": 408, "title": "BRIEF-Proteostasis Therapeutics - Co & Astellas Pharma Entered Into Amendment No. 6 To Collaboration & License Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T15:17:00.000+03:00", "replies_count": 0, "uuid": "b6dccfee93c5b2e42dc152b3e5d20778ae303606"}, "author": "", "url": "https://www.reuters.com/article/brief-proteostasis-therapeutics-co-astel/brief-proteostasis-therapeutics-co-astellas-pharma-entered-into-amendment-no-6-to-collaboration-license-agreement-idUSFWN1S00J9", "ord_in_thread": 0, "title": "BRIEF-Proteostasis Therapeutics - Co & Astellas Pharma Entered Into Amendment No. 6 To Collaboration & License Agreement", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-proteostasis therapeutics - co & astellas pharma", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "to collaboration & license agreement reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "co & astellas pharma", "sentiment": "none"}, {"name": "astellas pharma inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 17 PM / Updated 6 minutes ago BRIEF-Proteostasis Therapeutics - Co & Astellas Pharma Entered Into Amendment No. 6 To Collaboration & License Agreement Reuters Staff 1 Min Read \nApril 23 (Reuters) - Astellas Pharma Inc: \n* PROTEOSTASIS THERAPEUTICS - ON APRIL 20, CO & ASTELLAS PHARMA ENTERED INTO AMENDMENT NO. 6 TO COLLABORATION & LICENSE AGREEMENT DATED NOVEMBER 4, 2014 \n* PROTEOSTASIS THERAPEUTICS SAYS AMENDMENT EXTENDS RESEARCH TERM FOR INITIAL PROJECT UNDER ASTELLAS AGREEMENT TO DEC 4, 2018 - SEC FILING Source text: ( bit.ly/2F9O9I5 ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-04-23T15:17:00.000+03:00", "crawled": "2018-04-23T15:26:18.037+03:00", "highlightTitle": ""}